Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

(R)-TIMOLOL CRS (20 MG)

(R)-TIMOLOL CRS (20 MG)

NA

DISCOVER
Bromazepam for system suitability - * psy CRS, 15mg

Bromazepam for system suitability - * psy CRS, 15mg

1812-30-2

DISCOVER
HYDROCODONE  HYDROGEN TARTRATE 2.5-HYDRATE CRS - * NARC (10

HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE CRS - * NARC (10

34195-34-1

DISCOVER
BENZOPHENONE CRS (40 MG)

BENZOPHENONE CRS (40 MG)

119-61-9

DISCOVER
TELMISARTAN CRS (30 MG)

TELMISARTAN CRS (30 MG)

144701-48-4

DISCOVER
TELMISARTAN FOR PEAK IDENTIFICATION CRS (15 MG)

TELMISARTAN FOR PEAK IDENTIFICATION CRS (15 MG)

144701-48-4

DISCOVER
TAMSULOSIN HYDROCHLORIDE CRS (10 MG)

TAMSULOSIN HYDROCHLORIDE CRS (10 MG)

106463-17-6

DISCOVER
TAMSULOSIN IMPURITY D CRS (10MG)

TAMSULOSIN IMPURITY D CRS (10MG)

NA

DISCOVER
TAMSULOSIN IMPURITY H CRS (10MG)

TAMSULOSIN IMPURITY H CRS (10MG)

1510821-28-9

DISCOVER
TAMSULOSIN RACEMATE CRS (10 MG)

TAMSULOSIN RACEMATE CRS (10 MG)

106463-17-6

DISCOVER
LEFLUNOMIDE CRS (100 MG)

LEFLUNOMIDE CRS (100 MG)

75706-12-6

DISCOVER
SPECTINOMYCIN SULFATE TETRAHYDRATE CRS (15 MG)

SPECTINOMYCIN SULFATE TETRAHYDRATE CRS (15 MG)

64058-48-6

DISCOVER